Cambridge Heart: FDA 510(k) Clearances, Shared Predicate Lineage, and Recall History (1996 to 2010)
Consolidated U.S. FDA 510(k) premarket clearance cohort in Cardiovascular (primary filing hub: FL) reconciled with CDRH and openFDA historical recall notices from 1996 to 2010.
Review 17 FDA 510(k) clearances, 1 recalled K-numbers, and 1 cumulative 1976 to 2026 CDRH recall notices for Cambridge Heart on Predicate Ledger.
| Regulatory Metric | Verified Value |
|---|---|
| Entity Classification | FDA 510(k) Applicant Manufacturer |
| Clinical Advisory Specialty | Cardiovascular (Panel CV) |
| Cleared FDA 510(k) Submissions (1976 to 2026) | 17 clearances (0 California, 0.0%) |
| Cleared 510(k)s Linked to a Recall Notice | 1 K-numbers (cohort below n >= 20 rate floor) |
| Cumulative Historical Recall Notices (1976 to 2026) | 1 notices (0 Class I, 1 Class II, 0 Class III) |
| Currently Open vs Historical Recall Status | Cumulative 1976 to 2026 FDA archive total (1 notices); verify live open vs terminated status per notice in dossier |
| Implantable and Life-Sustaining Clearances | 0 implantable (0.0%) and 0 life-sustaining |
| Median FDA 510(k) Review Duration | 61 days (90th percentile: 182 days) |
Cumulative recall counts span 1976 to 2026 across U.S. FDA CDRH and openFDA public archives and combine closed historical notices with any currently open field actions. Browse all device cohorts, 20 clinical specialties, Shared 510(k) Predicate Lineage Stage, or reconciliation methodology.
Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.